2024 International Congress Archives - Page 166 of 181

Daily-life Sensor Based Measurement of Tremor Presence and Amplitude

K. Ocran, D. Hepp, J. van Hilten, V. Exadaktylos, R. Weijer (Leiden, Netherlands)
Dandy-Walker syndrome. A case study.

GM. Mussagaliyeva (Almaty, Kazakhstan)
Data-driven image-based subtyping and staging of neurodegeneration in Parkinson’s disease

J. Ha, G. Park, JS. Lee, JH. Ahn, W. Kim, JW. Cho, H. Kim, J. Youn (Seoul, Republic of Korea)
Deciphering the Role of Auranofin-Loaded Nanoparticles Against Rotenone Model of Parkinson’s Disease: Via GSK-3β/ Nrf2/HO-1 Signaling Pathways

D. Soni, P. Kumar (Bathinda, India)
Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)
Declining Lymphocyte Count and Lymphocyte-to-Neutrophil Ratio Following Parkinson’s Disease Diagnosis.

J. Kenny, R. Torricelli, A. Zirra, A. Noyce, D. Gallagher, T. Periñán, C. Budu, T. Boyle, KC. Dey (London, United Kingdom)
Decoding Fatigue in Parkinson’s Disease: Exploring Multifactorial Associations

F. Sarmento, G. Lamp, V. Srikar Lavu, A. S. Madamangalam, J. K. Wong (Gainesville, USA)
Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism

M. Acharya (Kharagpur, India)
Decrease in Walking Ability with Increased Functional Connectivity between Multiple Brain Areas in Parkinson’s Disease

ZZ. Zhu, JL. Wu, NB. Yu, JD. Han, J. Wang, Y. Wang (tianjin, China)
Deep Brain Stimulation (DBS) Improves Parkinsonism Caused by Osmotic Demyelination Syndrome (ODS)

T. Zhang, JC. Wu, HT. Li, Q. Wang, C. Zhang, Y. Yu, W. Yue, SQ. Liang (Tianjin, China)
Deep Brain Stimulation Complications in Parkinson’s Disease Patients: A 15-year Single-Centre Review

J. Cheong, S. Welch, M. Nasir, R. Matar, H. Low, A. Misbahuddin (London, United Kingdom)
Deep brain stimulation contact selection using Neurophysiology and Artificial intelligence

V. Lavu, J. Cagle, T. de Araujo, C. de Hemptinne, J. Wong (Gainesville, USA)
Deep Brain Stimulation during pregnancy: A systematic review of the literature

N. Pacheco-Barrios, K. Acurio, F. Váscones-Román, A. Flores-Gavino, I. Calisaya-Madriaga, W. Rios-Garcia, L. Aguilar-Alvarez, J. Rolston (Boston, USA)
Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome

H. Kaur, T. Goble, A. Fenoy, R. Ramdhani (Great neck, USA)
Deep Brain Stimulation for Primary Refractory Tinnitus: A Systematic Review

L. Basner, D. Zeitler, S. Schwartz, A. Bansal, K. Krause, F. Farrokhi (Seattle, USA)
Deep brain stimulation for severe dystonia associated with Wilson’s disease: A prospective multicentre meta-analysis of Nof1 trials

C. Laurencin, M. Bonjour, D. Grabli, A. Poujois, C. Demilly, E. Moro, V. Leclert, C. Karachi, G. Polo, B. Kassai, A. Portefaix, S. Thobois (Lyon, France)
Deep Brain Stimulation From the Perspective of Relatives and Caregivers: A Qualitative Analysis and Caregiver Burden

TUC. Saltoglu, YSK. Sücüllü Karadağ (İNCEK, Turkey)
Deep Brain Stimulation in Dystonia: Investigating Differential Response by Dystonia Distribution

S. Yarlagadda, M. Patel, S. Rajagopalan, H. Jinnah, S. Factor, S. Miocinovic, L. Scorr (Decatur, USA)
Deep Brain Stimulation in Tourette Syndrome: Characteristics of Three Patients Pre and Post Implantation

G. Young, R. Shults, L. Osborne, S. Bick, D. Isaacs (Nashville, USA)
Deep brain stimulation Intraoperative imaging: False errors in the era of artificial intelligence

V. Paramanandam, R. Alugolu, A. Sukumaran, R. Kandadai, R. Borgohain (Chennai,, India)
Deep Brain Stimulation of bilateral ventral intermediate nucleus in a patient with spinocerebellar ataxia type 12

YM. Sun, LQ. Lang, B. Shen, J. Hu, JJ. Wu (Shanghai, China)
Deep brain stimulation of bilateral ventral intermediate nucleus in patients with neuronal intranuclear inclusion disease

YM. Sun, LQ. Lang, J. Hu, JJ. Wu (Shanghai, China)
Deep brain stimulation of globus pallidus internus for monogenic dystonia

A. Gamaleya, S. Asriyants, A. Poddubskaya, A. Dekopov, A. Tomskiy (Moscow, Russian Federation)
Deep Brain Stimulation of the Subthalamic Nuclei in Advanced Parkinson’s Disease what Effects on Motor Non-motor and Neuropsychological Functions a Monocentric Prospective Study with a 12-month Follow-up

V. Leclercq, B. Delsaut, V. Donckels, S. Dethy (Sint-Pieters-Leeuw, Belgium)
Deep Brain Stimulation Surgery – Hurdles and Maladies!

A. Vijayaraghavan, S. Krishnan, D. P, S. Sachithanandan (Thiruvananthapuram, India)
Deep brain stimulation-evoked potentials as an avenue to optimize stimulation outcomes in Parkinson’s disease

B. Bahners, L. Goede, G. Meyer, L. Poser, L. Hart, A. Kühn, A. Horn (Boston, USA)
Deep Brain Stimulators in Parkinson`s subthalamic nucleus: A Study of Decade Follow-Up

L. Neerati, V. Raju, G. Ramaraju (Hyderabad, India)
Deep learning-based Prediction of Gait Dysfunction in Parkinson’s Disease using Quantitative Diffusion MRI from Brain Network Regions of Interest

C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)
Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI

C. Raimondo, L. Singanamala, M. Alizadeh (Philadelphia, USA)
Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.

G. Ilina, D. Khasanova, Z. Zalyalova, A. Katok (Kazan, Russian Federation)
Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report

CP. Gasmara, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)
Delineating the Molecular and Clinical Spectrum of Epilepsy-Dyskinesia Syndromes in Children (The Epilepsy-Dyskinesia Spectrum Study)

V. Quiroz, A. Kunta, A. Tam, N. Battaglia, K. Yang, A. Pinto, L. Soliani, P. da Silva, S. Desai, M. Iype, W. Lim, J. Necpál, H. Jones, J. Pérez-Sánchez, D. Crosiers, E. Unal, R. Pons, D. Ebrahimi-Fakhari (Brookline, USA)
Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA

B. Puccio, Y. Xu, J. Acquaviva, E. Feinstein (Newark, USA)
Dentate Deep Brain Stimulation for Cerebellar Ataxia: Long Term Outcomes

C. França, J. Diniz, I. Paraguay, D. de Andrade, V. Silva, R. Galhardoni, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)
Dentato-Rubro-Thalamic Tract Deep Brain Stimualtion for Essential Tremor: Stimulation Parameters and Clinical Outcomes

M. Schiess, E. Tharp, J. Martinez-Lemus, R. Ritter Iii, R. Abuamouneh, E. Rodarte, A. Fenoy (Houston, USA)
Deposition of phosphorylated TDP-43 around the tip of deep brain stimulation leads

G. Beck, R. Yamashita, Y. Yonenobu, K. Maeda, S. Murayama, H. Mochizuki (Suita city, Japan)
Depression and Cognitive Phenotype in Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression Scale.

C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J F. Ayala-Rico, J M. Márquez, F. Rojas, P A. Gutiérrez-Lenis, K. Rivera, S. Guerrero (Cali, Colombia)
Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

C A. Hurtado-Gonzalez, J F. Ayala-Rico, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, D A. Reyes-Torres, P A. Gutiérrez-Lenis, L M. Saldarriaga, C O. Moreno (Cali, Colombia)
Dermal 4R-Tau seeding as a novel biomarker for Progressive Supranuclear Palsy

I. Martinez-Valbuena, D. Olszewska, M. Sousa, T. Abkur, N. Bendahan, N. Reyes, M. Emamikhah Abarghouei, C. Ghadery, L. Armengou Garcia, J. Liao, C. Tan, SM. Fereshtehnejad, H. Alotibi, JC. Vargas-Gonzalez, NC. Dimal, J. Li, P. Bhakta, R. Cheung, J. Sasitharan, N. Visanji, S. Fox, C. Tartaglia, A. Lang, G. Kovacs (Toronto, Canada)
Design, synthesis and pharmacological evaluation of 16-pyridylmethylene derivatives of steroidal oximes as antiparkinsonian agents in MPTP-injected mice.

R. Singh, R. Bansal (Chandigarh, India)
Designing a Device for Real-time Monitoring and Digital Integration of Non-motor Symptoms

C. Gundler, A. Wiederhold, F. ückert (Hamburg, Germany)
Detecting impulsivity through speech in patients with Parkinson’s Disease: A principle proof study

T. Thies, E. Mallick, S. Jost, J. Tröger, M. Barbe (Cologne, Germany)
Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers

K. Smith, J. Williamson, T. Quatieri (Worcester, USA)
Determinants of nocturnal arterial hypertension in Parkinson’s disease patients in Cameroon

D. Gams Massi, J. Ndjock, A. Magnerou, Y. Mapoure Njankouo (Douala, Cameroon)
Determining and Leveraging Local Ancestry to Assess Individual-Level Risk: from the Global Parkinson’s Genetics Program

G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)
Determining Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data

C. Venuto, K. Herbst, K. Kieburtz (Rochester, USA)
Determining the Direction of segmented DBS Micro Electrodes through the EEG

K. Balmuri, V. Rama Raju (Hyderabad, India)
Determining the optimal filtering method for the removal of gait-related movement artefacts from EEG acquired from People with Parkinson’s Disease

B. Wijntjes (Dublin, Ireland)
Developing a selection framework for digital measures of Parkinson’s disease progression for the EJS ACT-PD trial

R. Ellis-Doyle, ML. Zeissler, C. Gonzalez-Robles, M. Bartlett, S. Collins, S. Del-Din, S. Haar, M. Hu, A. Jha, C. Lambert, A. Noyce, R. Petty, K. Pushparatnam, L. Rochester, C. Siu, G. Mills, A. Schrag, T. Foltynie, C. Carroll, A. Yarnall (London, United Kingdom)
Developing a Supervised Machine Learning Model for Long-Term Cognitive Status Prediction in Parkinson Disease

L. Saadatpour, A. Vijayakumari, D. Floden, H. Fernandez, B. Walter (Cleveland, USA)
Developing a Supportive Care and Wellness Program for Parkinson’s Patients

K. Farnes, H. Ooi, N. Hellmers, M. Lopez, H. Sarva (New York, USA)
Developing a Virtual Brick-Building Group for Veterans with Movement Disorders

J. Kaplan, C. Kausek, J. Lehosit (Richmond, USA)
Developing Composite Digital Measures for Tracking Parkinson’s Disease (PD) Progression using a Comprehensive Machine Learning-based Framework

S. Zhai, J. Ren, J. Shen, S. Chatterjee, Y. Xu, A. Liaw, V. Svetnik, O. Patil, ER. Dorsey, J. Adams, M. Dockendorf, R. Baumgartner (Rahway, USA)
Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors

K. Ho, C. Chen, S. Shin, S. Li, N. Kowahl, L. Evers, M. Meinders, L. Shih, B. Bloem, A. Siderowf, R. Kapur (South San Francisco, USA)
Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment

A. Hand, J. Slodkowska-Barabasz, J. Milne, A. Mccarthy, K. Greenwell (Newcastle-upon-Tyne, United Kingdom)
Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies

I. Ruiz Barrio, A. Horta Barba, A. Puig Davi, I. Aracil Bolaños, A. Quattrone, S. Martinez Horta, J. Kulisevksy, J. Pagonabarraga (Barcelona, Spain)
Development of a Beta-sensing Pathway in Deep brain stimulation to optimise utility of Local field potential recordings using the Percept system. (Newcastle Beta-sensing Algorithm – NBA)

M. Gibbs, R. Mills, A. Hussain, A. Jenkins, C. Nicholson, N. Pavese, D. Ledingham (Newcastle upon Tyne, United Kingdom)
Development of a National Initiative for the Professionalization of Parkinson Nurses – Results from Germany

M. van Munster, J. Stümpel, O. Fründt, A. Becker, T. Warnecke, C. Eggers, T. Mestre, T. Clemens, K. Czabanowska (Marburg, Germany)
Development of an AAV-mediated artificial miRNA targeting human alpha-synuclein (α-syn) as a potential gene therapy for Synucleinopathies

S. Basu, V. Singh, N. Gattone, J. Li, B. Wicks, X. Huang, E. Fabyanic, S. Wang, M. Li, X. Qian, G. Rivera-Pena, C. Li, Z. Yu, P. Raman, E. Kostuk, MG. Biferi, E. Ramsburg (Philadelphia, USA)
Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment

C. Schrader (Hannover, Germany)
Diabetic striatopathy with stroke – like symptoms: A case report

A. Alonso, C. Araque, B. Marquez (Bogotá, Colombia)
Diagnosing Young-Onset and Familial Parkinson’s Disease Using an Extensive Targeted Panel

HL. Chiang, YC. Lee (Taipei, Taiwan)
Diagnostic Challenges in Functional Neurological Disorder: Convergent Psychogenic Non-Epileptic Seizures and Psychosis

D. Nolasco, R. Holbert, B. Carr (Gainesville, USA)
Diagnostic challenges with novel SCA variants: A case of STUB1 mutation

D. Vijaywargiya, A. Frank, T. Chabrashvili (Liverpool, USA)
Diagnostic Spectrum in a Cohort of Atypical Atypical Parkinsonism

P. Katragadda, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Differences in Molecular and Ultrastructural profiles of astroglia and microglia in substantia nigra of two different mice strains in normal aging and experimental Parkinsonism

P. Alladi, A. Abhilash, U. Bharti, R. Santhosh Kumar, M. Philip, B. Chandrasekhar Sagar (Bangalore, India)
Differences in Oculometric Measures between Patients with LRRK2-associated and Idiopathic Parkinson’s Disease

R. Djaldetti, E. Raveh, J. Reiner, L. Franken, E. Harpaz, R. Kreitman, E. Ben-Ami (Petah Tikva, Israel)
Differences in regional activity levels between healthy controls, PD-nFOG, and PD-FOG as measured by ALFF and fALFF using resting-state fMRI.

T. Davis, Z. Mari, V. Mishra (Birmingham, USA)
Differential Diagnosis of Parkinsonism with 18F-FP-CIT PET using a Self-supervised Deep Learning Model

GY. Lee, J. Won, S. Jo, J. Lee, S. Lee, N. Kim, SJ. Chung (Seoul, Republic of Korea)
Differential Symptom Cluster Responses and Predictors to Repetitive Transcranial Magnetic Stimulation Treatment in Parkinson’s Disease：A Retrospective Study

J. Sun, P. Hu (hefei, China)
Differentiating Progressive Supranuclear Palsy from Corticobasal Syndrome Using Cortical Diffusion MRI

M. Torso, G. Ridgway, I. Hardingham, S. Chance (Oxford, United Kingdom)
Differentiating the Local Field Potential Oscillations in Low and Beta Range in Parkinson`s and Dystonic Movement Disorder

S. Konda, R. Venkateshwara, K. Balmuri (Hyderabad, India)
Diffusion MRI and Machine Learning Distinguish Alzheimer’s Disease and Dementia with Lewy Bodies

R. Chen, W. Wang, A. Barmpoutis, D. Vaillancourt (Gainesville, USA)
Digital health technology (DHT) derived features as sensitive measures of disease progression in early Parkinson’s disease under stable dopaminergic treatment

F. Lipsmeier, S. Lambrecht, S. Fraessle, Y. Gazizova, D. Kwasny, P. Wacht, B. Fehlmann, T. Kustermann, M. Lindemann, W. Popp, K. Taylor, R. Postuma (Basel, Switzerland)
Discriminating alpha-synuclein strains in Parkinson’s disease

I. Schniewind, S. Bräuer, E. Dinter, BH. Falkenburger (Dresden, Germany)
Disease Burden and Treatment in Patients With Essential Tremor in the United States: Real-World Evidence From a Cross-Sectional Survey of Physicians and Patients

J. Williams, A. Gillespie, L. Harrison, S. Thomas, A. Sillah, L. Barbato, J. Lin, S. Shah (Bakersfield, USA)
Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study

YM. Sun, C. Chen, XY. Zhou, FT. Liu, JJ. Wu, J. Wang (Shanghai, China)
Disease-related comprehensive motor pattern derived from 2D single RGB video as a biomarker for early and prodromal Parkinson disease

JH. Shin, SM. Lee, CH. Jeong, R. Yu, SH. Ha, S. Kim, B. Jin, KA. Woo, KY. Jung, JY. Lee, HJ. Kim, B. Jeon (Seoul, Republic of Korea)
Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)
Disrupted Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort Study

Y. Li, J. Liu (shanghai, China)
Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease

P. Marcott, A. Nelson (San Francisco, USA)
Distinct Gut Microbiome in Parkinson’s disease Based on the Presence of Premotor Rapid-Eye Movement Sleep Behavior Disorders: Exploring the Alpha-synuclein

S. Jo, J-Y. Lee, J. Lee, J-W. Bae, SJ. Chung (Seoul, Republic of Korea)
Distinct pattern of synaptic loss in Parkinson’s disease depression and initial findings from the Yale Ketamine PD (KET-PD) trial

M. Ansari, Y. Yang, S. Elliott, M. Naganawa, P. Honhar, M. Dias, S. Henry, J. Ropchan, R. Comley, N. Nabulsi, Y. Huang, R. Carson, S. Finnema, S. Nikayin, S. Tinaz, D. Matuskey, G. Sanacora, S. Holmes (New Haven, USA)
Distinct patterns of Gene Expression in Skin-biopsy Derived Fibroblasts of Patients with Parkinson’s disease

T. Ntetsika, I. Markaki, A. Damdimopoulos, M. Zeitelhofer, P. Tsitsi, M. Zeitelhofer Adzemovic, P. Svenningsson (Stockholm, Sweden)
Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging

JS. Park, JY. Gwak (Busan, Republic of Korea)
Distress Tolerance in Patients with Tremor Disorders

P. Sheehan, K. Pyle, M. Coleman, D. Sblendorio, D. Talkington, Y. Deng, A. Murray, A. Memon, N. Jasinski, M. Moreno-Escobar, J. Frey (Morgantown, USA)
Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease

B. Heffernan, S. Sillau, M. Sleyster, M. Fullard (Aurora, USA)
Do Lower Doses of Botulinum Neurotoxin Type-A Offer a Longer Duration of Effect and Superior Efficacy in Patients with Cervical Dystonia?

A. Kundrick, H. Fernandez (Cleveland, USA)
Do Proton Pump Inhibitors Increase the Risk of Parkinson’s Disease? A systematic review and meta-analysis

S. Karki, A. Parajuli (Kathmandu, Nepal)
Does cannabis increase one’s risk for a fall in Parkinson’s disease?: cross-sectional analysis of self-report balance problems and freezing of gait

M. Landers, A. Dockery, A. Hernandez, C. Miyashiro (Las Vegas, USA)
Dopa-responsive ataxia with compound heterozygous variants in MRE11

A. Dugar, E. Levine, M. Barbosa, W. Tse (New York, USA)
Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease.

D. Ortiz-Zacarias, S. Castillo-Torres, M. Cansino-Torres, J. Trejo-Ayala, B. Chávez-Luevanos, I. Estrada-Bellmann (Monterrey, Mexico)
Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line

J. Hall, R. Islam, D. Nolasco, B. Carr (GAINESVILLE, USA)
Dopamine Dysregulation Syndrome Outcomes following Pallidal Deep Brain Stimulation in Parkinson’s Disease

N. David, S. Factor, R. Tripathi, L. Higginbotham (Atlanta, USA)
Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease

V. Dzialas, G. Bischof, K. Möllenhoff, A. Drzezga, T. van Eimeren (Cologne, Germany)
Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson’s disease

J. Tanimura, T. Yamamoto, Y. Shigemoto, N. Sato, Y. Takahashi (Kodaira, Tokyo, Japan)
Dopaminergic Adverse Events With 24-hour Subcutaneous Infusion of ND0612

S. Isaacson, O. Rascol, H. Sarva, R. Hauser, F. Stocchi, N. Lopes, L. Salin, J. Pereira, N. Giladi (Boca Raton, USA)
Dopaminergic alterations in patients with Alzheimer’s disease

M. Azharuddin, M. Sharma (New Delhi, India)
Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)
Dose-dependent alterations of lysosomal activity and alpha-synuclein level in peripheral blood monocyte-derived macrophages and SH-SY5Y neuroblastoma cell line by upon inhibition of mTOR kinase activity

A. Bezrukova, K. Basharova, G. Baydakova, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)
Driving assessment in older patients with Parkinson’s in United Kingdom.

M. Khwaja, T. Nanayakkara, G. Pun, R. Miah, N. Butt, A. Chatterjee (Reading, United Kingdom)
Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol

H. Hikichi, H. Nishijima, F. Mori, I. Kinoshita, C. Murakami, M. Tomiyama (Hirosaki, Japan)
Drug-induced tremors: A scoping review to assess knowledge gaps, controversies, and future directions

S. Desai, D. Desai (Anand, India)
Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease

E. Pegolo, F. Cucinotta, I. Hossain, B. Ishihara, M. Hart, E. Pereira, F. Morgante, A. Fasano, L. Ricciardi (Padova, Italy)
Dual Pathways of Holmes Tremor Suggested from the Experience of Deep Brain Stimulation

N. Murase, M. Tanaka, T. Shimokawara, K. Murase, H. Hirabayashi (Nara city, Japan)
Dual-Task Cost of Walking While Using a Smartphone: A Comparison Study of Older Adults with and Without Cognitive Decline

G. Christofoletti, T. Lino, S. Sobrinho Junior (Campo Grande, Brazil)
Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis

C. Geroin, C. Artusi, S. Camozzi, G. Imbalzano, S. Aldegheri, L. Lopiano, N. Bombieri, M. Tinazzi (Verona, Italy)
Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia

Z. Simsek, M. Lipp, S. Groves, Z. Huang, M. Fei, J. Voyvodic, C. Petty, M. Lutz, N. Bukhari-Parlakturk (Durham, USA)
Dysphagia is Frequent in early Parkinson´s Disease. Results from a 5-year Follow-up Study.

D. Santos, T. de Deus, C. Cores, C. íñiguez, L. Samaniego, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, I. Pareés, P. Sánchez Alonso, G. Alonso Losada, M. Morales, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, M. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)
Dysregulated Anti-Viral Response in LRRK2 Mice Following Infection with H1N1 Influenza Induces DA Neuron Loss in the SNpc.

K. Crowther, R. Smeyne, E. Kozina (Philadelphia, USA)
Dystonia and Impact on Employment in a Spanish Cohort

E. Casas, E. Cañada, R. Berbegal, S. Lozano, G. Cabañas, N. Mena, M. Campos, R. Pastor, A. Patiño, I. Muro, L. Lopez-Manzanares, A. Alonso-Canovas (Madrid, Spain)
DystoniaDBSNet: A novel deep learning biomarker of predictive treatment outcomes in dystonia

DR. Yao, N. Sharma, K. Bhatia, E. Mulroy, J. Wong, Y. Yu, H. Akram, T. Foltynie, P. Limousin, L. Zrinzo, K. Simonyan (boston, USA)
DYT-KMT2B generalized dystonia managed with GPi-DBS

A. Santana, A. Azzoni, M. Sakuma, F. Godinho, E. Barbosa, C. Gusmão, R. Cury (São Paulo, Brazil)